Medicamen Biotech has informed that it has enclosed the disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, received from Shivalik Rasayan & Growel Remedies for purchase and sale of equity shares.
The above information is a part of company’s filings submitted to BSE.